» Articles » PMID: 24288622

The Afferent Visual Pathway: Designing a Structural-functional Paradigm of Multiple Sclerosis

Overview
Journal ISRN Neurol
Specialty Neurology
Date 2013 Nov 30
PMID 24288622
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a disease of the central nervous system (CNS) believed to arise from a dysfunctional immune-mediated response in a genetically susceptible host. The actual cause of MS is not known, and there is ongoing debate about whether this CNS disorder is predominantly an inflammatory versus a degenerative condition. The afferent visual pathway (AVP) is frequently involved in MS, such that one in every five individuals affected presents with acute optic neuritis (ON). As a functionally eloquent system, the AVP is amenable to interrogation with highly reliable and reproducible tests that can be used to define a structural-functional paradigm of CNS injury. The AVP has numerous unique advantages as a clinical model of MS. In this review, the parameters and merits of the AVP model are highlighted. Moreover, the roles the AVP model may play in elucidating mechanisms of brain injury and repair in MS are described.

Citing Articles

OCT-Based Retina Assessment Reflects Visual Impairment in Multiple Sclerosis.

Stolowy N, Gutmann L, Lupke M, David T, Dorr M, Mayer C Invest Ophthalmol Vis Sci. 2025; 66(2):39.

PMID: 39946137 PMC: 11827617. DOI: 10.1167/iovs.66.2.39.


Microstructural Changes in Intraretinal Layers and Macular Structures of People with Epilepsy Measured Using Optical Coherence Tomography.

Cakar M, Baysal L, Garip R, Guldiken B Noro Psikiyatr Ars. 2024; 67(3):202-207.

PMID: 39258133 PMC: 11382560. DOI: 10.29399/npa.28410.


Spotlight on Trans-Synaptic Degeneration in the Visual Pathway in Multiple Sclerosis.

Filippatou A, Calabresi P, Saidha S, Murphy O Eye Brain. 2024; 15:153-160.

PMID: 38169913 PMC: 10759909. DOI: 10.2147/EB.S389632.


Identifying Optical Coherence Tomography Markers for Multiple Sclerosis Diagnosis and Management.

Cujba L, Stan C, Samoila O, Drugan T, Benedec Cutas A, Nicula C Diagnostics (Basel). 2023; 13(12).

PMID: 37370972 PMC: 10297350. DOI: 10.3390/diagnostics13122077.


VEP Score of a Left Eye Had Predictive Values for Achieving NEDA-3 over Ten Years in Patients with Multiple Sclerosis.

Miletic-Drakulic S, Miloradovic I, Jankovic V, Azanjac-Arsic A, Lazarevic S Sensors (Basel). 2022; 22(22).

PMID: 36433445 PMC: 9696926. DOI: 10.3390/s22228849.


References
1.
Saidha S, Sotirchos E, Ibrahim M, Crainiceanu C, Gelfand J, Sepah Y . Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012; 11(11):963-72. PMC: 3533139. DOI: 10.1016/S1474-4422(12)70213-2. View

2.
Salmi T . Critical flicker frequencies in MS patients with normal or abnormal pattern VEP. Acta Neurol Scand. 1985; 71(5):354-8. DOI: 10.1111/j.1600-0404.1985.tb03212.x. View

3.
Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, Graham S . Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann Neurol. 2008; 64(3):325-31. DOI: 10.1002/ana.21474. View

4.
Moura A, Teixeira R, Oiwa N, Costa M, Feitosa-Santana C, Callegaro D . Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test. Vis Neurosci. 2008; 25(3):463-8. DOI: 10.1017/S0952523808080437. View

5.
Gelfand J, Nolan R, Schwartz D, Graves J, Green A . Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012; 135(Pt 6):1786-93. PMC: 3359753. DOI: 10.1093/brain/aws098. View